a public good project by the
Synthesis
Company
of California

© 2026

Charry Shuk-Ching Hui | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

Charry Shuk-Ching Hui

University of Hong Kong(HK)

Research Areas

Cancer, Hypoxia, and Metabolism, Retinoids in leukemia and cellular processes, Fibroblast Growth Factor Research

Most-Cited Works

→ Repurposing Resmetirom suppresses MASH-associated hepatocellular carcinoma, with mechanistic implications of MDK/LRP1-mediated metabolic reprogramming and immunosuppression(2026)